Carina Domaneschi

Carina Domaneschi

Auto-generated profile, based on publicly available information

Carina Domaneschi

Department of Stomatology School of Dentistry University of São Paulo São Paulo São Paulo Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2011 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
DMDébora B Massarente
Débora B Massarente
CDCarina Domaneschi
Carina Domaneschi
HMHeloísa Hs Marques
Heloísa Hs Marques
SASamantha B Andrade
Samantha B Andrade
DGDaniela Goursand
Daniela Goursand
JAJosé Lf Antunes
José Lf Antunes
Background: Children with Acquired Immune Deficiency Syndrome (AIDS) exhibit impaired dental status, which can affect their quality of life. This study assessed the oral health-related quality of life of these patients and associated factors. Methods: The "Child Perceptions Questionnaire 11-14", rating overall and domain-specific (oral symptoms, functional limitations, emotional well being, and social well being) oral health-related quality of life (OHR-QoL) was completed by 88 children with AIDS assisted in the Child Institute, Sao Paulo, Brazil. Parents or guardians provided behavioural and socio-demographic information. The clinical status was provided by hospital records. OHR-QoL covariates were assessed by Poisson regression analysis. Results: The most affected OHR-QoL subscale concerned oral symptoms, whose rate was 23.9%. The direct answer for oral health and well being made up a rate of 47.7%. Brushing the teeth less than two times a day and viral load exceeding 10,000 HIV-RNA copies per millilitre of plasma were directly associated (p < 0.05) with a poorer oral health-related quality of life. Conclusions: Children with more severe AIDS manifestations complained of poorer status of oral symptoms, functional limitations, emotional and social well being related to their oral health. Recognizing the factors that are associated with poorer OHR-QoL in children with AIDS may contribute to the planning of dental services for this population.

29 November 2010 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
CDC Domaneschi
C Domaneschi
DMDb Massarente
Db Massarente
RFRs de Freitas
Rs de Freitas
HMHh de Sousa Marques
Hh de Sousa Marques
CPCr Paula
Cr Paula
JAJlf Antunes
Jlf Antunes

15 March 2017 in European Journal of Dental Education
Verified
Journal Article
Closed access
PDF file
COChristiano de Oliveira-Santos
Christiano de Oliveira-Santos
CTCamila Tirapelli
Camila Tirapelli
CRClarissa Teles Rodrigues
Clarissa Teles Rodrigues
CDCarina Domaneschi
Carina Domaneschi
SMSolange Aparecida Caldeira Monteiro
Solange Aparecida Caldeira Monteiro

30 April 2006 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
Verified
Journal Article
Closed access
JKJuliana Y. Kawamura
Juliana Y. Kawamura
CDCarina Domaneschi
Carina Domaneschi
DMDante A. Migliari
Dante A. Migliari
SSSuzana Orsini Machado de Sousa
Suzana Orsini Machado de Sousa

1 January 2022 in Brazilian Oral Research
Verified
Journal Article
Open access
WCWladimir Gushiken de Campos
Wladimir Gushiken de Campos
CECamilla Vieira Esteves
Camilla Vieira Esteves
CGCamila de Barros Gallo
Camila de Barros Gallo
CDCarina Domaneschi
Carina Domaneschi
AAAna Cecilia Correa Aranha
Ana Cecilia Correa Aranha
CLCelso Augusto Lemos
Celso Augusto Lemos
Oral leukoplakia is a potentially malignant disorder, defined as a white plaque that cannot be diagnosed as another known disease or disorder, and has an increased risk of malignancy. The aim of the present study was to evaluate the results of CO2 laser treatment in a well-defined cohort of patients with oral leukoplakia in order to identify the occurrence of clinical outcomes of relapse, resolution, or malignancy after treatment. The study group comprised 37 patients. Before treatment, clinical photographs and incisional biopsies were obtained in all cases. In addition, the post-treatment results were documented using photographs. Evaluation of treatment results was performed by an independent researcher who had not performed the surgery. The minimum, maximum, and mean values of continuous variables were calculated. Statistically significant relationships were tested using the Cox regression analysis. A survival curve was constructed according to the Kaplan-Meier method to analyze the malignant transformation and recurrence of oral leukoplakia. The clinical outcomes analyzed were resolution, recurrence, and malignancy. The mean follow-up period was 36 months (range, 6-239 months). In 13/37 patients, leukoplakia recurred between 6 and 93 months (mean, 38.2 months). In 8/37 patients, a malignant transformation occurred (mean, 50.6 months). In 16/37 patients, lesion resolution occurred. No risk factor was statistically significant for malignancy or recurrence of lesions. The treatment of the lesions by CO2 laser was efficient in the removal of the lesions; however, it did not avoid the clinical outcomes of recurrence or malignancy.

1 January 2009 in Brazilian Dental Journal
Verified
Journal Article
Open access
PDF file
AMAna Carolina Fragoso Motta
Ana Carolina Fragoso Motta
CDCarina Domaneschi
Carina Domaneschi
MKMarilena Chinali Komesu
Marilena Chinali Komesu
CSCacilda da Silva Souza
Cacilda da Silva Souza
VAValéria Aoki
Valéria Aoki
DMDante Antonio Migliari
Dante Antonio Migliari
The aim of this study was to evaluate the efficacy of a 0.05% clobetasol propionate ointment administered in trays to 22 patients with desquamative gingivitis in a double-blind, crossover, placebo-controlled trial. Patients received container number 1 and were instructed to apply the ointment 3 times a day for 2 weeks, and to reduce the application to once a day in the third week. Next, the patients were then instructed to discontinue the treatment for 2 weeks, and were then given container 2, used in the same way and for the same length of time as container 1. Regarding signs, 17 patients presented some improvement, while 5 experienced worsening with clobetasol propionate. With the placebo, 14 patients presented some improvement, and 8 patients presented worsening. For symptoms, there was complete improvement in 2 patients, partial improvement in 12, no response in 7, and worsening in 1 with clobetasol propionate. With the placebo, there was partial improvement in 8 patients, no response in 12 and worsening in 2. No statistically significant difference was found between clobetasol and placebo (p>0.05). Within the period designed to treat the gingival lesions of the patients, clobetasol propionate did not significantly outperform the placebo.